Journal article
Quality of life with ablation or medical therapy for ventricular arrhythmias: A substudy of VANISH
Abstract
BACKGROUND/OBJECTIVE: We compared health-related quality of life (HRQoL) in patients randomized to escalated therapy and those randomized to ablation for ventricular tachycardia in the VANISH trial.
METHODS: HRQoL was assessed among VANISH patients at baseline and 3-, 6-, and 12-month follow-up visits. Four validated instruments were used: the SF-36, the implanted cardioverter defibrillator (ICD) Concerns questionnaire (ICDC), the Hospital …
Authors
Gula LJ; Doucette S; Leong‐Sit P; Tang ASL; Parkash R; Sarrazin J; Thibault B; Essebag V; Tung SK; Deyell MW
Journal
Journal of Cardiovascular Electrophysiology, Vol. 29, No. 3, pp. 421–434
Publisher
Wiley
Publication Date
3 2018
DOI
10.1111/jce.13419
ISSN
1045-3873